vimarsana.com

Page 4 - தேசிய மையம் க்கு தொற்று நோய்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study points to a novel strategy for developing broad-spectrum vaccines against coronaviruses

Scientists from Duke-NUS Medical School and the National Centre for Infectious Diseases (NCID) found that 2003 SARS survivors who have been vaccinated with the Pfizer-BioNTech mRNA vaccine produced highly potent functional antibodies that are capable of neutralizing not only all known SARS-CoV-2 variants of concerns (VOCs) but also other animal coronaviruses that have the potential to cause human infection.

First-of-its-kind clinical trial network established in Asia to treat and prevent drug-resistant infections

Wellcome Trust has provided a grant of S$2.5 million to the National University of Singapore to establish the Asian Clinical Research Network to conduct antimicrobial clinical research to develop the most effective ways to treat and prevent life-threatening drug-resistant infections.

askST: What s the point of vaccines if I can still get Covid-19 and end up in ICU?

New study boosts hopes for a broad vaccine to combat COVID-19 variants and future coronavirus outbreaks

New study boosts hopes for a broad vaccine to combat COVID-19 variants and future coronavirus outbreaks
asiaresearchnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaresearchnews.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.